Gardasil Mandates Have Begun: Are Schools now Shills for Big Pharma?

Passive Agressive Raven
by Dr. Sherri Tenpenny

Just when you think it can’t get any worse…it does.

Rhode Island has announced that the HPV vaccine, Gardasil, has been added as a requirement to attend the 7th grade. In an article published in the Washington Times, Tricia Washburn, chief of the Office of Immunization for the Rhode Island Department of Health, said:

“The bottom line is that HPV is the most sexually transmitted disease in the U.S.” she said. “We are interested in protecting the public health. We feel it shouldn’t be treated any differently than any of the other vaccines recommended by the CDC.”

Seventh graders are 12-13 years of age. What is behind this mandate? Does Rhode Island have a problem with promiscuous teens, prompting this CDC representative to be concerned about protecting the public from human papilloma virus disease?

Read more…

Another Doctor Testifies: ‘HPV Vaccine Does Not Protect Against Cancer’ Truthstream Media

Truthstream Media

Leading OBGYN Dr. Uzi Beller, described as “an international authority on gynecological cancers who treats patients on a daily basis” was recently quoted in the Jerusalem Post:

“If HPV vaccine…were proven to prevent cervical cancer, that would be something else. But it hasn’t. The US Food and Drug Administration checks for safety of the vaccine, but not for efficacy. There is no evidence that the vaccine protects against cervical cancer, only [that it] counters the virus itself. No decrease in invasive cervical cancer… in the vaccinated population has been documented so far.”

Beller testified at a meeting of 40 specialists in oncology, gynecology, vaccines and women’s health regarding HPV vaccines in Tel Aviv earlier this month. The Israeli Health Ministry was set to begin a widescale vaccination program of 65,000 14-year-old  school girls this fall, but the program has been halted for further review after multiple doctors have come forward voicing concerns that these vaccines’ scant potential benefits do not outweigh the myriad adverse health effects the HPV vaccine can — and has — caused.

Beller went on to note:

“HPV is different from all other vaccines. It is not a vaccination against cervical cancer but against a virus that in some cases causes a premalignant condition, and in a small number of cases, a malignancy. In a year in Israel, there are 180 cases of cervical cancer, and half [of those with the disease] die of it. [This] is a rate of five per 100,000 residents – the lowest rate of cervical cancer in the world. One would have thus have to vaccinate 20,000 girls to prevent one case.”

Big Pharma companies Merck (Gardasil) and GlaxoSmithKline (Cervarix) raked in billions on their HPV vaccines last year, most likely on the fears of concerned parents and patients under 30 who paid nearly $400 for a set of three shots to try and spare their adolescents or themselves from possibly getting HPV-related diseases like cervical cancer and genital warts.

Unfortunately though, as other doctors have pointed out in the past, HPV vaccines do not prevent cancer.

In fact, Gardasil only claims to protect those vaccinated with it from four of more than 100 strands of human papilloma virus and even if someone were to contract one of those strands, it does not automatically mean that person will even get cancer, regardless of Merck’s aggressive marketing campaigns based entirely on fear of it.

Even one of the top scientists that helped create Gardasil came forward to admit that the incidents of cervical cancer in the U.S. are already very low and, because the majority of HPV cases resolve themselves within one (70%) or two (90%) years’ time, the vaccine really will not have an effect on the cervical cancer rates either way.

On top of that, more than 30,000 adverse events have been reported since these vaccines were approved for sale, a much higher number than the estimated 12,000 cases of cervical cancer reported annually in America. The National Vaccine Injury Program recently paid $6 million to Gardasil victims. Negative side effects reported include Guillain-Barre syndrome, seizures, severe pain, fatigue syndrome, tremors, infertility, spontaneous miscarriage and even death. Over 60 people have died so far after getting the HPV vaccine.

Recently, the Japanese government has announced it will officially stop recommending HPV shots due to over 2,000 adverse reactions reported in the country. All Japanese healthcare providers will now be required to tell patients that the government does not recommend the vaccine.

HPV vaccines were fast-tracked, and their approval marks one of the most corrupt and obvious revolving door cases in the history of the U.S. government. The former U.S. Centers for Disease Control and Prevention (CDC) Director from 2002 to 2009 Dr. Julie Gerberding directly helped pave the way for approval of Merck’s Gardasil vaccine with a 2004 report to Congress on preventing HPV. After she left her position at the CDC in 2009, Dr. Gerberding walked right through the revolving door between our government and Big Pharma to accept a position as President of Merck’s Vaccine Division where she currently works.

Dr. Beller went on to assert he is not even against taking vaccines himself, he just holds deep reservations specifically about the efficacy of HPV vaccines:

“I am not at all against vaccines. I just underwent the oral polio vaccination as the Health Ministry instructed medical institutions to give the two drops to every doctor who is in direct contact with patients…if the vaccine prevented cervical cancer, I would be in favor. The vaccine [was hailed] in 2003 as being ‘the beginning of the end for cervical cancer,’ but it was exaggerated.”

The Lead Vaccine Developer Comes Clean So She Can “Sleep At Night”

Real Farmacy (also Federal Jack)

Dr. Diane Harper was the lead researcher in the development of the human papilloma virus vaccines, Gardasil and Cervarix. She is the latest to come forward and question the safety and effectiveness of these vaccines. She made the surprising announcement at the 4th International Public Conference on Vaccination, which took place in Reston, Virginia on Oct. 2nd through 4th, 2009. Her speech was supposed to promote the Gardasil and Cervarix vaccines, but she instead turned on her corporate bosses in a very public way. When questioned about the presentation, audience members remarked that they came away feeling that the vaccines should not be used.

“I came away from the talk with the perception that the risk of adverse side effects is so much greater than the risk of cervical cancer, I couldn’t help but question why we need the vaccine at all.”  – Joan Robinson

Dr. Harper explained in her presentation that the cervical cancer risk in the U.S. is already extremely low, and that vaccinations are unlikely to have any effect upon the rate of cervical cancer in the United States. In fact, 70% of all H.P.V. infections resolve themselves without treatment in a year, and the number rises to well over 90% in two years. Harper also mentioned the safety angle. All trials of the vaccines were done on children aged 15 and above, despite them currently being marketed for 9-year-olds. So far, 15,037 girls have reported adverse side effects from Gardasil alone to the Vaccine Adverse Event Reporting System (V.A.E.R.S.), and this number only reflects parents who underwent the hurdles required for reporting adverse reactions.

At the time of writing, 44 girls are officially known to have died from these vaccines. The reported side effects include Guillian Barré Syndrome (paralysis lasting for years, or permanently — sometimes eventually causing suffocation), lupus, seizures, blood clots, and brain inflammation. Parents are usually not made aware of these risks. Dr. Harper, the vaccine developer, claimed that she was speaking out, so that she might finally be able to sleep at night.

“About eight in every ten women who have been sexually active will have H.P.V. at some stage of their life. Normally there are no symptoms, and in 98 per cent of cases it clears itself. But in those cases where it doesn’t, and isn’t treated, it can lead to pre-cancerous cells which may develop into cervical cancer.”  – Dr. Diane Harper

US vaccine court pays $6 million to Gardasil victims, most claims not yet settled

The Refusers

“This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded,” said Judicial Watch President Tom Fitton. “Public health officials should stop pushing Gardasil on children.”

(Washington, DC) – Judicial Watch announced today that it has received documents from the Department of Health and Human Services (HHS) revealing that its National Vaccine Injury Compensation Program (VICP) has awarded $5,877,710 dollars to 49 victims in claims made against the highly controversial HPV (human papillomavirus) vaccines. To date 200 claims have been filed with VICP, with barely half adjudicated.

The documents came in response to a February 28, 2013, Judicial Watch lawsuit against HHS to force the department to comply with a November 1, 2012, Judicial Watch Freedom of Information Act (FOIA) request (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:13-cv-00197)). On March 12, 2013, The Health Resources and Services Administration (HRSA), an agency of HHS, provided Judicial Watch with documents revealing the following information:

Only 49 of the 200 claims filed have been compensated for injury or death caused from the (HPV) vaccine. Of the 49 compensated claims 47 were for injury caused from (HPV) vaccine the additional 2 claims were for death caused due to the vaccine.
92 (nearly half) of the total 200 claims filed are still pending. Of those pending claims 87 of the claims against (HPV) vaccine were filed for injury, the remaining 5 claims were filed for death.

59 claims have been dismissed outright by VICP. The alleged victims were not compensated for their claims against the HPV vaccine. Of the claims dismissed, 57 were for injuries, 2 were for deaths allegedly caused by the HPV vaccine.
The amount awarded to the 49 claims compensated totaled 5,877,710.87 dollars. This amounts to approximately $120,000 per claim.

VICP is a Health and Human Services program that compensates patients who have been adversely affected by certain vaccines. The HHS web site describes the program as a “no-fault alternative to the traditional tort system,” and it covers 16 specific classes of vaccines, including HPV vaccines which were added in 2007.

From its inception, the use of HPV (human papillomavirus) vaccines for sexually transmitted diseases has been hotly disputed. According to the Annals of Medicine: “At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination.”

“This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded,” said Judicial Watch President Tom Fitton. “Public health officials should stop pushing Gardasil on children.”

In addition to obtaining records from the FDA through the agency’s Vaccine Adverse Event Reporting System (VAERS) which has documented thousands of adverse reactions to Gardasil, Judicial Watch also published a special report in 2008 detailing Gardasil’s approval process, side effects, safety concerns and marketing practices.

Related:  JW Investigates HPV Injury Compensation Program

Brit Scientists Show HPV Vaccine Is Not Justified Anywhere

Gaia Health
by Heidi Stevenson

Just as it is in the west, the HPV vaccine is being heavily marketed in India. The heavy pressure to roll it out has resulted in tragic deaths of girls given the vaccines. Now, a report by the British Journal of the Royal Society of Medicine has come out with a study demonstrating that the HPV vaccines, Gardasil and Cervarix, cannot be justified in India. More scandalous, though, is that their results clearly reflect that these vaccines are even less justified in the western world, including the USA, UK, Europe, Canada, and Australia. That, though, is never mentioned in their report..

The primary point brought out by the study(1) is that the rate of cervical cancer is not high enough to justify the cost and risks associated with Gardasil and Cervarix vaccines. Further, the authors noted that the rate of cervical cancer in India has dropped dramatically in a little more than 20 years, from 43 cases per 100,000 in 1982-83 down to 22 per 100,000 in 2004-05. This point alone should clarify that the cause of cervical cancer is likely mostly associated with something that’s controllable in the environment. India’s standard of living has risen dramatically in the last 25 years, and that may be the most significant factor in cervical cancer rates.

The Program for Appropriate Technology in Health (PATH), which has close ties with the Bill Gates Foundation(2), is the primary force behind pushing HPV vaccines in India. Of course, Merck and GlaxoSmithKline (GSK) also actively push them because they manufacture the vaccines.

The British study has harsh words for the conclusions that PATH reached. They quote the PATH document, “Shaping a Strategy to Introduce HPV Vaccines in India, “Results from the HPV Vaccines’ states that ‘in raw numbers, India has the largest burden of cancer of the cervix of any country worldwide.” Then, they state.

This claim is not supported by the references, moreover data from the cancer registries in Gujarat or the Cancer Atlas were not cited.

PATH selected Andhra Pradesh and Gujarat ‘based on cervical cancer disease burden’ and because they were ‘in the middle range for certain variables (e.g., immunization coverage)’. There are no references provided for this statement.

Of the five studies that PATH cites in relation to cervical cancer or HPV epidemiology, one study could not be traced; the HBCR report is not comprehensive and does not provide age-adjusted cervical cancer incidence rates; and the three remaining studies did not examine epidemiology of cancer but reported on HPV prevalence and type distribution. Only one study was conducted in Andhra Pradesh and none in Gujarat. The three studies were conducted in rural populations in the south, and urban populations in the south and north of India.

In other words, the British study found that the claims made by PATH are not supported by any evidence!

The authors concluded:

Neither the epidemiological evidence nor current cancer surveillence systems justify the general rollout of a HPV vaccination programme either in India or in the two states where PATH was conducting its research. HPV vaccination programmes should only proceed where there is both strong epidemiological evidence and where there are adequate surveillance and monitoring systems.

The cervical cancer rate does not justify the costs or risks for the HPV vaccine.

Study Implications for Industrialized Nations

This study about the lack of justification of the HPV vaccine in India has strong implications for its massive rollout in the west. All we need to do is compare the incidence of cervical cancer in India with those of western nations:

India United           States of America          United Kingdom
22 per 100,000       8.0 per 100,000(3)       10.5 per 100,000(4)

Even in terms of cancer rates, these are low. In the UK, the total annual rate of cancer as of 2008 was 466.3/100,000(4). In the US, the rate for 2008 was 517.6/100,000(5). The study did not give an overall cancer rate in India. It did, though, focus on the fact that the mortality rate (not incidence, but actually death rate) of Indian women from diabetes and cardiovascular diseases was 283/100,000, and compared it with the death rate from cervical cancer: 7.7/100,000.

In the US and UK, the cervical cancer rate is less than half that found in India. This study found that giving the HPV vaccine makes no sense in light of both its cost and harmful effects. This doesn’t even consider the fact that no cause-and-effect connection between HPV and cancer has ever been shown, so there is nothing to demonstrate that the very expensive HPV vaccines even accomplish what they claim.

The implication of this study for the industrialized nations is that the HPV vaccines make no sense, even without taking into account the question of whether they actually do prevent cervical cancer. Cervical cancer is a relatively rare disease. It isn’t even in the top ten cancers. Whether we like to accept it or not, the fact is that cost of medical treatment does matter. If we spend too much on one thing, then we won’t have enough to spend on something else. So, we must make rational decisions.

So, the question is: Does it make any sense to promote a vaccine for HPV? Consider these facts:

There is no proof that it prevents cancer.
The cost of the vaccine is extremely high and must be repeated at least three times for initial coverage and again every few years.
The rate of cervical cancer is quite low.
The cure rate of cervical cancer is quite high.
The adverse effects are devastating.
Clearly, it does not. Whether in India or a western nation, there simply is no justification for the HPV vaccines—unless, of course, you’re Merck or GSK.

Video of Study Author Discussing Problems Found in the PATH Claims

Professor Allyson Pollock, one of the paper’s researchers, is interviewed in this video. She states quite clearly that it will take at least 30 years to know if the vaccine works to prevent cancer and specifically states that PATH is hugely irresponsible in pushing the HPV vaccines in India. She clarifies quite clearly why the HPV vaccine makes no sense in India. It’s a shame she didn’t expand her comments to the use of these vaccines in the west [8:55]:

FDA Approved Gardasil Without Safety Testing: Proof in FDA Document


Would you willingly use a pharmaceutical product or subject your child to one if it hasn’t been safety tested?

If you’ve had the Gardasil vaccine or have allowed your daughter, and now your son, to be injected, that’s precisely what has happened. The proof has been hidden in plain sight on the FDA’s website since 2006.

The Food and Drug Administration’s (FDA’s) approval letter went out with statements saying that both short and long term studies were to be done.

Approval was immediate, not predicated on the results of those studies.

From the approval letter sent to Merck in 2006:

“You have committed to conduct a short-term safety surveillance study in a U.S. Managed Care Organization (MCO). The study will include approximately 44,000 vaccinated subjects who will be followed for 60 days for assessment of general short-term safety (i.e., emergency room visits, hospitalizations, and deaths). The subjects will also be followed for 6 months subsequent to vaccination for new autoimmune disorders, rheumatologic conditions, or thyroiditis. … The final study report will be submitted by September 30, 2009.”

That references a single study that was to be performed in the United States for a short term 60 day assessment and another short term 6 month assessment.

It’s now nearly 2½ years after the date that study was supposed to be submitted to the FDA. I searched the FDA’s database for a reference to it … any reference to it. The search terms used were “merck gardasil safety assessment”. I also tried to find a reference in the journal literature.

All that exists on the FDA site is information based on the sorely inadequate VAERS (Vaccine Adverse Event Reporting System) data, where it’s estimated that less than 10% of all adverse events are reported.

In A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD, I found a reference to a study that appears to be a match for the requirement stated in the FDA’s letter. It was described as being done in association with Merck, planned for an MCO, and to include 44,000 vaccinated subjects. The sample size is referenced as being an FDA requirement. In fact, the study is clearly one published in the Internal Medicine study that I reported on in Farcical Study of Gardasil Safety: Medscape Gives CME Training Credit for It. It was published in November 2011, more than 2½ years later than the Gardasil approval requirement specified.

The FDA didn’t pull Gardasil from the market for the lack of safety data that Merck had agreed to produce. But it’s even worse than that. The requirement, as stated above, was for reporting of adverse events that occurred up to 60 days after vaccination and up to 6 months after. The study didn’t even touch on those time spans. It reported on a select group of diseases, which were chosen by the FDA. As the Farcical Study… article indicates, they are not the problems that are generally reported as adverse effects of Gardasil.

Clearly, the FDA does not stand as a guardian of the public’s health. They operate as a pusher of Big Pharma’s products. The Gardasil disaster demonstrates it clearly:

The FDA approved the vaccine without adequate testing for either safety or efficacy.
When the required testing hadn’t been done, or at least no report of it has been produced, the FDA allowed Merck to continue marketing the product.

When the study was finally published, it did not contain the documentation required by the original agreement.

In October 2009, shortly after the September 2009 deadline for reporting on the safety test had passed, the FDA actually expanded application of Gardasil to include boys.

To further exemplify the FDA’s utter lack of concern for the public’s health, the same document that granted approval to market Gardasil specified that efficacy against cervical cancer and prevention of the HPV variants included in the vaccine be monitored in a group of 5,500 Norwegian women. They are also supposed to investigate “pregnancy outcomes, especially congenital anomalies” in the study participants.

According to A summary of the post-licensure surveillance initiatives…, this study appears to be in process. But one must wonder how it will be adulterated, as the previous one was—and as the FDA clearly collaborated in the first study’s adulteration by providing a list of specific diseases to search for, rather than simply report on any and all adverse effects, how likely is it that December 31, 2018 will come and go with no study report or that the report, when it is produced, is done in a manner designed to give the false impression that Gardasil is safe?

Clearly, the FDA is not acting for the benefit of the people:

The FDA approved Gardasil without first making reasonable assurance that it was safe in anyone.
The FDA approved the mass use of Gardasil without having any information to indicate whether it will cause fetal harm. Remember thalidomide? Apparently, the FDA doesn’t.

The FDA turned their heads when Merck didn’t come up with the first safety study. They left Gardasil on the market.
The FDA approved Gardasil’s use in boys shortly after the first safety study wasn’t delivered. Can we assume that this approval was planned even before initial approval was given? It seems that the FDA was punked by Merck when it didn’t produce the trial, but went ahead with their approval plans anyway.
The FDA aided Merck in scamming the report of that first study by specifying conditions that weren’t those that people were reporting.
What more could we possibly need to know that the FDA is corrupt and should be disbanded?

Here is the FDA’s letter to Merck granting approval to market Gardasil and specifying the study requirements, which are highlighted in yellow, so you can scroll to them quickly:

June 8, 2006 Approval Letter – Human
Papillomavirus Quadrivalent (Types 6, 11,
16, 18) Vaccine, Recombinant

June 8, 2006 Approval Letter – Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant.pdf